OSE Immunotherapeutics Provides Business and Corporate Update
OSE Immunotherapeutics Provides Business and Corporate Update NANTES, France, May 30, 2024 – 6:15pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today provided business and corporate update after…